Compile Data Set for Download or QSAR
Report error Found 66 Enz. Inhib. hit(s) with all data for entry = 50032730
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333813(3-(4-Morpholino-6-(pyridin-2-yl)pyrimidin-2-yl)phe...)
Affinity DataIC50: 44nMAssay Description:Inhibition of human recombinant PI3K p110gamma after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333813(3-(4-Morpholino-6-(pyridin-2-yl)pyrimidin-2-yl)phe...)
Affinity DataIC50: 62nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333813(3-(4-Morpholino-6-(pyridin-2-yl)pyrimidin-2-yl)phe...)
Affinity DataIC50: 100nMAssay Description:Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333821(3-(2-Morpholino-6-(pyridin-2-ylmethoxy)pyrimidin-4...)
Affinity DataIC50: 110nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333819(3-(2-Morpholino-6-(2-(pyridin-4-yl)ethylamino)pyri...)
Affinity DataIC50: 140nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333815(3-(4-Morpholino-6-(pyridin-4-yl)pyrimidin-2-yl)phe...)
Affinity DataIC50: 140nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333815(3-(4-Morpholino-6-(pyridin-4-yl)pyrimidin-2-yl)phe...)
Affinity DataIC50: 150nMAssay Description:Inhibition of human recombinant PI3K p110gamma after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333820(3-(6-Morpholino-2-(2-(pyridin-2-yl)ethylamino)pyri...)
Affinity DataIC50: 180nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333828(3-(4-(3,4-Dichlorophenyl)-6-morpholinopyrimidin-2-...)
Affinity DataIC50: 200nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333815(3-(4-Morpholino-6-(pyridin-4-yl)pyrimidin-2-yl)phe...)
Affinity DataIC50: 200nMAssay Description:Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333834(3-(6-Morpholino-2-(2-(pyridin-4-yl)ethylamino)pyri...)
Affinity DataIC50: 230nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333833(3-(6-Morpholino-2-(2-(pyridin-3-yl)ethylamino)pyri...)
Affinity DataIC50: 250nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333817(3-(2-Morpholino-6-(2-(pyridin-2-yl)ethylamino)pyri...)
Affinity DataIC50: 250nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333814(3-(4-Morpholino-6-(pyridin-3-yl)pyrimidin-2-yl)phe...)
Affinity DataIC50: 260nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333818(3-(2-Morpholino-6-(2-(pyridin-3-yl)ethylamino)pyri...)
Affinity DataIC50: 260nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333814(3-(4-Morpholino-6-(pyridin-3-yl)pyrimidin-2-yl)phe...)
Affinity DataIC50: 340nMAssay Description:Inhibition of human recombinant PI3K p110gamma after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333821(3-(2-Morpholino-6-(pyridin-2-ylmethoxy)pyrimidin-4...)
Affinity DataIC50: 370nMAssay Description:Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333820(3-(6-Morpholino-2-(2-(pyridin-2-yl)ethylamino)pyri...)
Affinity DataIC50: 380nMAssay Description:Inhibition of human recombinant PI3K p110gamma after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333814(3-(4-Morpholino-6-(pyridin-3-yl)pyrimidin-2-yl)phe...)
Affinity DataIC50: 440nMAssay Description:Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333809(4-(1H-indazol-4-yl)-6-morpholino-N-(2-(pyridin-4-y...)
Affinity DataIC50: 440nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333800(4-(4-(1H-indazol-4-yl)-6-(pyridin-2-ylmethoxy)pyri...)
Affinity DataIC50: 500nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333796(6-(1H-indazol-4-yl)-2-morpholino-N-(2-(pyridin-3-y...)
Affinity DataIC50: 660nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333827(3-(4-(4-Chlorophenyl)-6-morpholinopyrimidin-2-yl)p...)
Affinity DataIC50: 690nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50331594(3-(2-morpholino-6-(pyridin-3-ylmethylamino)pyrimid...)
Affinity DataIC50: 720nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333821(3-(2-Morpholino-6-(pyridin-2-ylmethoxy)pyrimidin-4...)
Affinity DataIC50: 730nMAssay Description:Inhibition of human recombinant PI3K p110gamma after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333819(3-(2-Morpholino-6-(2-(pyridin-4-yl)ethylamino)pyri...)
Affinity DataIC50: 740nMAssay Description:Inhibition of human recombinant PI3K p110gamma after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333797(6-(1H-indazol-4-yl)-2-morpholino-N-(2-(pyridin-4-y...)
Affinity DataIC50: 770nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333808(4-(1H-indazol-4-yl)-6-morpholino-N-(2-(pyridin-3-y...)
Affinity DataIC50: 820nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333817(3-(2-Morpholino-6-(2-(pyridin-2-yl)ethylamino)pyri...)
Affinity DataIC50: 830nMAssay Description:Inhibition of human recombinant PI3K p110gamma after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333832(3-(6-Morpholino-2-(pyridin-4-ylmethylamino)pyrimid...)
Affinity DataIC50: 860nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333835(3-(6-Morpholino-2-(pyridin-2-ylmethoxy)pyrimidin-4...)
Affinity DataIC50: 860nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333831(3-(6-Morpholino-2-(pyridin-3-ylmethylamino)pyrimid...)
Affinity DataIC50: 880nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333816(3-(2-Morpholino-6-(pyridin-2-ylmethylamino)pyrimid...)
Affinity DataIC50: 900nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333818(3-(2-Morpholino-6-(2-(pyridin-3-yl)ethylamino)pyri...)
Affinity DataIC50: 960nMAssay Description:Inhibition of human recombinant PI3K p110gamma after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333830(3-(6-Morpholino-2-(pyridin-2-ylmethylamino)pyrimid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333829(3-(2-Morpholino-6-(pyridin-4-ylmethylamino)pyrimid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333807(4-(1H-indazol-4-yl)-6-morpholino-N-(2-(pyridin-2-y...)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333795(6-(1H-indazol-4-yl)-2-morpholino-N-(2-(pyridin-2-y...)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333812(4-(6-(1H-indazol-4-yl)-2-(pyridin-2-ylmethoxy)pyri...)
Affinity DataIC50: 1.35E+3nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333819(3-(2-Morpholino-6-(2-(pyridin-4-yl)ethylamino)pyri...)
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333818(3-(2-Morpholino-6-(2-(pyridin-3-yl)ethylamino)pyri...)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333816(3-(2-Morpholino-6-(pyridin-2-ylmethylamino)pyrimid...)
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333817(3-(2-Morpholino-6-(2-(pyridin-2-yl)ethylamino)pyri...)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333810(4-(6-(1H-indol-6-yl)-2-(pyridin-2-ylmethoxy)pyrimi...)
Affinity DataIC50: 5.20E+3nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333820(3-(6-Morpholino-2-(2-(pyridin-2-yl)ethylamino)pyri...)
Affinity DataIC50: 5.20E+3nMAssay Description:Inhibition of human recombinant PI3K p110beta after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333811(N-(4-(6-morpholino-2-(pyridin-2-ylmethoxy)pyrimidi...)
Affinity DataIC50: 6.20E+3nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333802(4-(1H-indol-6-yl)-6-morpholino-N-(2-(pyridin-3-yl)...)
Affinity DataIC50: 7.20E+3nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333816(3-(2-Morpholino-6-(pyridin-2-ylmethylamino)pyrimid...)
Affinity DataIC50: 7.60E+3nMAssay Description:Inhibition of human recombinant PI3K p110gamma after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333801(4-(1H-indol-6-yl)-6-morpholino-N-(2-(pyridin-2-yl)...)
Affinity DataIC50: 8.90E+3nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
The Institute of Cancer Research

Curated by ChEMBL
LigandPNGBDBM50333806(N-(3-(6-morpholino-2-(2-(pyridin-4-yl)ethylamino)p...)
Affinity DataIC50: 9.10E+3nMAssay Description:Inhibition of human recombinant PI3K p110alpha after 1 hr by radiometric scintillation proximity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2011
Entry Details Article
PubMed
Displayed 1 to 50 (of 66 total ) | Next | Last >>
Jump to: